The miss in both earnings per share and sales estimates for Ekso Bionics Holdings suggests a negative short-term impact on the stock price. The reported decrease in losses per share year-over-year might offer some positive sentiment, but the miss on both key financial metrics is likely to weigh more heavily on investor sentiment and stock performance in the short term.